India’s pharmaceutical industry is one of the largest in the world – supplying vaccines, APIs, formulations, and life-saving drugs across domestic and global markets. Yet, behind this growth lies a critical vulnerability: cold chain inefficiencies.
Pharma products don’t forgive errors. A few hours of temperature deviation can lead to batch rejection, regulatory non-compliance, and patient risk. While facilities may look operational on paper, gaps during receiving, storage, and dispatch continue to erode value.